Efficacy and Safety of Bitopertin in Patients with Schizophrenia and Predominant Negative Symptoms: Subgroup Analysis of Japanese Patients from the Global Randomized Phase 2 Trial

OBJECTIVE: The aim of the present study was to perform a subgroup analysis of data from a phase II global, multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of bitopertin, a glycine reuptake inhibitor that activates N-methyl-D-aspartate receptors by...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirayasu, Yoshio, Sato, Shin-Ichi, Shuto, Norifumi, Nakano, Miwa, Higuchi, Teruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240458/
https://www.ncbi.nlm.nih.gov/pubmed/28096877
http://dx.doi.org/10.4306/pi.2017.14.1.63

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240458/
https://www.ncbi.nlm.nih.gov/pubmed/28096877
http://dx.doi.org/10.4306/pi.2017.14.1.63

Ejemplares similares